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Streptococcus pneumoniae is a leading cause of bacterial pneumonia worldwide. Given
the critical role of dendritic cells (DCs) in regulating and modulating the immune response
to pathogens, we investigated here the role of DCs in S. pneumoniae lung infections.
Using a well-established transgenic mouse line which allows the conditional transient
depletion of DCs, we showed that ablation of DCs resulted in enhanced resistance to
intranasal challenge with S. pneumoniae. DCs-depleted mice exhibited delayed bacterial
systemic dissemination, significantly reduced bacterial loads in the infected organs
and lower levels of serum inflammatory mediators than non-depleted animals. The
increased resistance of DCs-depleted mice to S. pneumoniae was associated with
a better capacity to restrict pneumococci extrapulmonary dissemination. Furthermore,
we demonstrated that S. pneumoniae disseminated from the lungs into the regional
lymph nodes in a cell-independent manner and that this direct way of dissemination
was much more efficient in the presence of DCs. We also provide evidence that
S. pneumoniae induces expression and activation of matrix metalloproteinase-9 (MMP-9)
in cultured bone marrow-derived DCs. MMP-9 is a protease involved in the breakdown
of extracellular matrix proteins and is critical for DC trafficking across extracellular
matrix and basement membranes during the migration from the periphery to the lymph
nodes. MMP-9 was also significantly up-regulated in the lungs of mice after intranasal
infection with S. pneumoniae. Notably, the expression levels of MMP-9 in the infected
lungs were significantly decreased after depletion of DCs suggesting the involvement
of DCs in MMP-9 production during pneumococcal pneumonia. Thus, we propose that
S. pneumoniae can exploit the DC-derived proteolysis to open tissue barriers thereby
facilitating its own dissemination from the local site of infection.
Keywords: Streptococcus pneumoniae, bacterial dissemination, respiratory infection, dendritic cells, pneumonia,
MMP-9
INTRODUCTION
The respiratory tract is a major portal of entry for airborne
pathogens. The most common cause of respiratory tract infec-
tions worldwide is Streptococcus pneumoniae (van der Poll and
Opal, 2009). Colonization of the human nasopharynx is the first
step in the interaction between S. pneumoniae and the human
host (Kadioglu and Andrew, 2004). From this location, the bac-
terium can spread to the lungs causing pneumonia, or further
disseminate systemically causing invasive diseases. The first line
of host defense against S. pneumoniae in the lungs involves res-
ident alveolar macrophages and recruited neutrophils (Dockrell
et al., 2003; Hahn et al., 2011). An additional immune cell pop-
ulation residing in the lungs is the dendritic cells (DCs). DCs
are potent antigen-presenting cells that play a critical role in the
induction of antigen-specific immune responses (Banchereau and
Steinman, 1998; Banchereau et al., 2000). In the periphery, DCs
have an immature phenotype characterized by high endocytic
activity and low T-cell stimulation potential (Banchereau et al.,
2000). After pathogen recognition, DCs undergo a coordinated
maturation program including the up-regulation of costimula-
tory molecules (CD40, CD80, and CD86) and MHC Class II,
the chemokine receptor CCR7, and the production of proinflam-
matory cytokines (TNF-α, IL-12, and IL-6) (Banchereau et al.,
2000). Mature DCs migrate via the afferent lymphatic vessels
into the draining mediastinal lymph nodes, where they can acti-
vate antigen-specific T lymphocytes (Banchereau et al., 2000). In
the lungs, DCs form an extensive network in close proximity to
the respiratory epithelial cells, where they function as immune
sentinels for sampling incoming pathogens (Lambrecht et al.,
2001; Vermaelen and Pauwels, 2005). After pathogen encounter,
airway DCs undergo maturation and rapidly migrate to the
T cell area of the draining mediastinal lymph nodes (Xia et al.,
1995). Pulmonary DCs have been reported to play an impor-
tant role in host defense against respiratory pathogens includ-
ing Legionella pnemophila (Ang et al., 2010), Bordetella pertussis
(Dunne et al., 2009), Cryptococus neoformans (Osterholzer et al.,
2009), and syncytial virus (Smit et al., 2006). Despite the clin-
ical relevance of pneumococcal pneumonia, scarce information
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is available regarding the role played by DCs during this infec-
tion. In vitro studies using low encapsulated or capsule-deficient
strains of S. pneumoniae have shown that pneumococcal pneu-
molysin inhibits human DC maturation (Littmann et al., 2009).
In addition, Noske et al. (2009) reported that expression of the
pneumococcal adherence and virulence factor A (PavA) protected
S. pneumoniae against recognition and phagocytosis by human
DCs. The role of DCs during S. pneumoniae in vivo infection has,
however, not been investigated so far. In spite of the fact that
experimental murine models cannot fully mimic the complexity
of human pneumococcal infections, there are far more similar-
ities than differences when comparing pneumonia in humans
and pneumonia in mice (Chiavolini et al., 2008). For exam-
ple, the accumulation of purulent exudate containing neutrophils
in the lungs takes place in both human and murine pneumo-
nia (Chiavolini et al., 2008). Furthermore, murine models have
been pivotal in the study of pneumococcal pathogenesis and they
have the potential to further direct future medical approaches to
affected patients.
In this study, we used bone marrow chimeras generated from
CD11c-DTR transgenic mice, which allows transient ablation
of DCs by administration of consecutive doses of diphtheria
toxin (DT), to define the specific role played by pulmonary DCs
during pneumococcal pneumonia. Strikingly, our results demon-
strated that depletion of DCs improved the resistance of mice
to S. pneumoniae infection. Furthermore, the beneficial effect
afforded by depletion of DCs was due to a significant reduction
of S. pneumoniae dissemination from the lungs to lymph nodes
and systemic tissue. These results provide strong evidence that
S. pneumoniae might exploit the capacity of DCs to breakdown
host barriers to facilitate its dissemination from the local site of
infection.
MATERIALS AND METHODS
ETHICS STATEMENT
Animal experiments were performed in strict accordance with
the European Health Law of the Federation of Laboratory
Animal Science Associations (FELASA). All experiments were
approved by the ethical board Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg in
Germany (Permit No. 33.11.42502-04-118/08).
BACTERIAL STRAINS AND GROWTH CONDITIONS
The S. pneumoniae strains D39 serotype 2 and S. pneumoniae
serotype 4, strain TIGR4 were grown routinely at 37◦C in Todd-
Hewitt broth (Sigma-Aldrich, Munich, Germany) supplemented
with 1% (w/v) yeast extract (Sigma-Aldrich) and 10% of heat-
inactivated FCS (GIBCO/Invitrogen, Eggenstein-Leopoldshafen,
Germany). Bacteria were grown to the Mid-Log phase (OD600),
collected by centrifugation for 10min at 4000 rpm, and washed
twice with sterile PBS.
MICE AND INFECTIONMODEL
BALB/c mice were purchased from Harlan-Winkelmann
(Borchen, Germany), B6.FVB-Tg [Itgax-DTR/GFP] 57Lan/J
(referred to as CD11c-DTR) transgenic mice (Jung et al., 2002)
were obtained from Steffen Jung (The Weizmann Institute of
Science, Rehovot, Israel). These transgenic mice express the
simian DT receptor on the CD11c promoter region, which allows
for selective depletion of DCs following the administration
of DT. To avoid the lethal effect observed after repeated DT
administration, bone marrow chimera mice were generated as
previously described (Bar-On and Jung, 2010). Briefly, 2.5 × 105
bone marrow cells from a CD11c-DTR donor were transferred
intravenously into BALB/c mice, which were lethally irradiated
(950 rads) 24 h earlier. The chimeric animals (referred to as
CD11c-DTR chimeras) were treated for 1 week with 0.04%
Baytril together with 0.054% glucose in their drinking water.
The CD11c-DTR chimeras were ready for experimental use at
8 weeks post-reconstitution. For continuous depletion of DCs,
CD11c-DTR chimeras received a daily intraperitoneal injection
of DT (Sigma-Aldrich) in PBS (8 ng/g body weight) starting
2 days before infection (Figure 1A). Treatment with DT did
not affect the amounts of B or T lymphocytes (Figure 1B).
However, the amount of neutrophils (Gr-1+ cells) was signifi-
cantly increased in the lungs of mice undergoing DT treatment
(Figure 1B).
For intranasal infection with S. pneumoniae, mice were anes-
thetized by intraperitonal injection with ketamine (70mg/kg;
Ketavet; Pharmacia & Upjohn, Erlangen, Germany) and xylazine
(Rompun® 2%, 20mg/kg; Bayer, Leverkusen, Germany) and
inoculated intranasally with 1 × 108 CFU of S. pneumoniae.
FLOW CYTOMETRY ANALYSIS
Cells were incubated for 5min with anti-CD32 antibodies
to block Fc receptors and then stained with PE-conjugated
anti-CD11c, APC-conjugated anti-CD11b, FITC-conjugated
anti-CD4, PE-conjugated anti-Gr-1 or PE-conjugated anti-B220
antibodies along with their isotype control antibodies and
incubated for 30min at 4◦C. Labeled cells were analyzed by flow
cytometry in a FACSCalibur™ (Becton Dickinson).
GENERATION OF BONE MARROW-DERIVED DENDRITIC CELLS
Bone marrow cells were flushed from murine femurs and tib-
ias and cultured for 6 days at 37◦C in RPMI 1640 (Invitrogen,
Paisley, UK) 5% FCS, 1% penicillin/streptomycin, 50 ng/ml of
recombinant mouse GM-CSF (granulocyte-macrophage colony-
stimulating factor; Miltenyi Biotech), and 10 ng/ml IL-4 (R&D
Systems, Wiesbaden-Nordenstadt, Germany). DCs were gently
washed and fed with fresh medium supplemented with GM-CSF
(25 ng/ml) and IL-4 (5 ng/ml) on days 2 and 4. On day 6, the
DC fraction was enriched using an OptiPrep™ (Axis-Shield, Oslo,
Norway) gradient. The purity of the resulting cell population con-
sisted of >80% of DCs as determined by flow cytometry analysis
using anti-mouse CD11c-PE antibodies (BD Pharmingen).
CYTOKINES AND CHEMOKINES DETECTION
Cytokines and chemokines were analyzed by multiplex bead
technology (Bio-Rad Inc., Hercules, CA, USA) according to the
manufacturer’s protocol.
ISOLATION AND PHENOTYPIC CHARACTERIZATIONOF LUNG CELLS
Lungs were enzymatically digested with 1mg/ml of collagenase F
(Sigma-Aldrich) and 50 U of DNase I (Sigma-Aldrich) in 500μl
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FIGURE 1 | Depletion of CD11c+ cells in the lungs of CD11c-DTR chimera
mice after treatment with successive doses of DT. CD11c-DTR mice were
injected with 1, 2, 3, or 4 successive doses of DT (8 ng/g body weight) or
PBS. Lungs were digested and transformed in single cell suspensions 24h
after treatment and stained with PE-conjugated anti-CD11c antibodies for
FACS analysis. (A) Representative histogram of CD11c expression in lung
cells of PBS-treated or DT-treated CD11c-DTR mice. (B) Percentage of
neutrophils (Gr-1+) (upper histograms), CD4+ lymphocytes (middle
histograms) and B cells (B220+) (lower histograms) in the lungs of
PBS-treated (left) or DT-treated (right) CD11c-DTR mice. The mean ± SD
percentages of positive cells are indicated in each histogram. Data shown are
representative of one out of three separate experiments.
RPMI 1640 at 37◦C for 30min. The resulting cell suspension was
filtered through a 100-μm strainer, resuspended in RPMI and
prepared for further analysis.
GENTAMICIN PROTECTION ASSAY
Mediastinal lymph nodes were transformed into a single cell
suspension, centrifuged at 900 rpm for 8min and the super-
natant was plated in 10-fold serial dilutions onto blood agar
plates to determine the number of extracellular bacteria. The
cell pellet was then incubated for 2 h in medium containing
100μg/ml of gentamicin to eliminate extracellular microorgan-
isms and collected by centrifugation. The cell pellet was washed,
disrupted after treatment with 50μl ddH2O and the amount of
viable intracellular bacteria determined after serial plating onto
blood agar.
DC VIABILITY TEST
Viability of infected DCs was determined using an FITC annexin
V apoptosis detection kit I (BD Biosciences) according to the
manufacturer’s instructions and analyzed by flow cytometry.
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DOUBLE DEPLETION OF DCs AND NEUTROPHILS
CD11c-DTR chimeras were injected daily with DT intraperi-
toneally starting 2 days before infection and intravenously
injected with 100μg of anti-mouse RB6 antibodies 1 day before
bacterial inoculation. Control mice received equivalent amounts
of isotype control antibodies in sterile PBS.
IMMUNOFLUORESCENCEMICROSCOPY
For double immunofluorescence of extracellular/intracellular
bacteria, DCs were seeded in sterile coverslips and infected
with S. pneumoniae for 2 h at a MOI of 20 bacteria per DC.
Coverslips were then rinsed to remove unbound cells, and
adherent cells were fixed with 3.7% formaldehyde. For double
immunofluorescence staining, extracellular bacteria were stained
with polyclonal rabbit anti-S. pneumoniae antibodies, followed
by Alexa green-conjugated goat anti-rabbit antibodies (Sigma-
Aldrich, Germany). After several washes, cells were permeabilized
by 0.025% Triton X-100 in PBS, washed again, and intracellu-
lar bacteria were stained by rabbit anti-S. pneumoniae antibodies,
followed by Alexa red-conjugated goat anti-rabbit antibodies
(Sigma-Aldrich). The fluorescence images were obtained with a
confocal laser scan microscope (BIO-RAD, Hercules, CA, USA).
Infected DCs showed no significant decrease in cell viability or
evidence of apoptosis (data not shown).
ANALYSIS OF mRNA EXPRESSION
Total RNA was extracted using the RNeasy Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s recommendations.
PCR amplification was performed using a LightCycler 480
Real Time PCR system (Roche Applied Science, Mannheim,
Germany) and Maxima SYBR Green qPCR Master Mix
(Fermentas, St. Leo-Rot, Germany). The sequence for MMP-9
sense primer was: 5′-GGGAAGGCTCTGCTGTTCAGC-3′, and
for the antisense primer: 5′-TCTAGAGACTTGCACTGCACG-
3′. The sequence for the ß-actin sense primer was: 5′-TGGAAT
CCTGTGGCATCCATGAAA-3′ and the antisense primer: 5′-
TAAAACGCAGCTCAGTAACAGTCCG-3′. Cycle threshold val-
ues for mmp-9 were normalized to the housekeeping gene
β-actin. The data were calculated using the Pfaffl equation (Pfaffl,
2001) and expressed as a ratio of the relative mRNA expres-
sion in infected samples as compared to that of the uninfected
controls.
GELATIN GEL ZYMOGRAPHY
Culture supernatant of uninfected and S. pneumoniae-infected
DCs at 24 h postinfection were mixed with equal volumes of 2 ×
SDS sample buffer containing 10% glycerol, 2% SDS, 0.00125%
bromophenol blue and 0.06M Tris (pH 6.8) and electrophoresed
in 10% SDS-PAGE containing 0.1% (w/v) bovine gelatin. Gels
were incubated in renaturing buffer (2.5% Triton X-100) at room
temperature for 20min and then incubated for at least 72 h at
37◦C in a buffer containing 5mM CaCl2, 0.2 M NaCl, 0.02%
(w/v) Brij-35, and 50mM Tris (pH 7.6). Thereafter, gels were
stained for 1 h with Coomassie Dye containing 0.06% Coomassie
Brilliant Dye G, 25% (v/v) methanol, 0.005% acidic acid, and
20mM EDTA. After destaining with 10% acidic acid, gels were
imaged on a Cano Scan 9000F.
In vivo VASCULAR PERMEABILITY ASSAY
Bone marrow-derived DCs were infected with S. pneumoniae
of 20 bacteria per DC for 90min. DCs were then washed
and further incubated in the presence of antibiotics (100μg/ml
gentamicin, 10μg/ml penicillin) at 37◦C and 5% CO2. The
culture supernatant was collected after 24 h of culture and
stored at −80◦C until use. Medium from uninfected DCs
as well as medium where only bacteria were added were
used as controls. Evans blue (30mg/kg body weight) was
injected intravenously into BALB/c mice. Fifty microliters of
the supernatant were injected intradermally into the dorsal
skin of anesthetized shaved mice. One hour later the mice
were sacrificed and Evans blue was extracted by incubation
of the tissue in 500μl formamide at 60◦C for 48 h. The vas-
cular leakage activity was then determined by quantitatively
measuring the extracted Evans blue by spectrophotometry at
620 nm using the Sunrise absorbance reader and Magellan™3
software.
STATISTICAL ANALYSIS
Data was analyzed using GraphPad Prism 4.0 (GraphPad soft-
ware). Comparison between groups was performed by the use
of non-parametric Mann–Whitney U-test. P-values ≤ 0.05 were
considered as significant.
RESULTS
DEPLETION OF DCs RESULTS IN ENHANCED RESISTANCE TO
S. pneumoniae INFECTION
To determine the relevance of DCs for the control of S. pneu-
moniae, CD11c-DTR chimera mice were depleted of DCs and
intranasally infected with a sublethal inoculum of S. pneumo-
niae strain D39 (1 × 108 CFU). During the first 24 h follow-
ing infection, the numbers of bacteria in the lungs recovered
from both DCs-depleted and non-depleted mice were nearly
identical (Figure 2A). Extrapulmonary pneumococci appeared
in the draining mediastinal lymph nodes by 24 h of infec-
tion in 80% of the non-depleted mice but only in 20% of
DCs-depleted animals (Figure 2B), indicating that bacteria dis-
semination from the lungs was more efficient in the pres-
ence of DCs. Dissemination of S. pneumoniae to the draining
lymph nodes was followed after 48 h by systemic dissemina-
tion to blood (Figure 2C) and peripheral organs such as spleen
(Figure 2D). Again, this dissemination occurred to a signifi-
cantly higher extent in non-depleted mice. By 48 h and 72 h of
infection, the amount of pneumococci in all organs was sig-
nificantly lower in DCs-depleted than in non-depleted mice.
Furthermore, non-depleted mice demonstrated more severe signs
of morbidity characterized by lethargy, ruffled fur and hunch-
backed posture after S. pneumoniae challenge than DCs-depleted
animals.
The superior resistance of DCs-depleted mice to S. pneumo-
niae was not strain-specific since similar results were obtained
with S. pneumoniae strain TIGR4 (see Figure S1 in supplementary
material). We also excluded a potential effect of the DT treatment
per se by demonstrating that wild-type BALB/c mice treated with
DT exhibited a similar infection kinetic than untreated animals
(see Figure S2 in supplementary material).
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FIGURE 2 | Bacterial burdens in the organs of DCs-depleted and
non-depleted mice after respiratory challenge with S. pneumoniae.
DCs-depleted (white symbols) and non-depleted (black symbols) CD11c-DTR
chimera mice were intranasally inoculated with 1 × 108 CFU of
S. pneumoniae D39 and the bacterial loads determined in the lungs (A),
mediastinal lymph nodes (B), blood (C), and spleen (D) at 24, 48, and 72h
after bacterial inoculation. Each symbol represents an individual animal.
Horizontal continuous lines indicate the mean value for non-depleted mice
and horizontal broken lines indicate the mean value for DCs-depleted mice.
One experiment out of three is shown. ∗p < 0.05 and ∗∗p < 0.01.
DCs-DEPLETEDMICE EXHIBIT LOWER LEVELS OF SYSTEMIC
INFLAMMATION AFTER INTRANASAL INOCULATIONWITH
S. pneumoniae THAN NON-DEPLETEDMICE
Determination of serum cytokines in DCs-depleted and non-
depleted mice at progressing times after bacterial inoculation
demonstrated that the systemic inflammatory response triggered
by S. pneumoniae infection was also much more tempered in
the absence of DCs. Thus, significantly lower levels of circulat-
ing serum IL-6 (Figure 3A), IFN-γ (Figure 3B), KC (Figure 3C),
IP-10 (Figure 3D) and MCP-1 (Figure 3E) were detected at 72 h
of infection in DCs-depleted than in non-depleted mice. These
results indicate that depletion of DCs results in attenuated sys-
temic inflammation in S. pneumoniae-infected mice.
DEPLETION OF DCs DOES NOT AFFECT THE RECRUITMENT OF
LEUKOCYTES INTO THE S. pneumoniae-INFECTED LUNGS
Given that DCs depletion improved the host resistance to S. pneu-
moniae, we investigated whether the superior resistance of DCs-
depleted mice was due to more efficient recruitment of cells
involved in bacterial clearance into the lungs. DCs-depleted
and non-depleted CD11c-DTR chimera mice were intranasally
infected with S. pneumoniae and the total amount of cells in
the lungs was determined before and at 24 h and 48 h after
bacterial inoculation. As shown in Figure 4A, a comparable time-
dependent increase in the total amount of cells recruited into
the infected lungs was observed in both DCs-depleted and non-
depleted mice. The recruitment of neutrophils (Figure 4B) or
CD4+ T cells (data not shown) was similar between both groups
at the different times of infection.
Interestingly, depletion of DCs after treatment with DT
induced a significant increase in the accumulation of neutrophils
within the lungs of treated mice (Figures 1B, 4B). This phe-
nomenon associated with DT treatment has been previously
described by Tittel et al. (2012). As neutrophils are the most
important innate immune cells for early defense against S. pneu-
moniae (Matthias et al., 2008; Standish and Weiser, 2009), it can
be hypothesized that a higher amount of neutrophils present
in the lungs of DT-treated mice previous to bacterial challenge
can be responsible for the lower bacterial burdens observed in
these animals at later time points. However, the fact that the
amount of bacteria in the lungs at 24 h after intranasal chal-
lenge is comparable in PBS- and DT-treated mice gives clear
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FIGURE 3 | Kinetics of serum cytokines and chemokines in DCs-depleted
and non-depleted mice during the course of S. pneumoniae infection.
DCs-depleted (white symbols) and non-depleted (black symbols) CD11c-DTR
chimera mice were challenged intranasally with 1 × 108 CFU of
S. pneumoniae D39 and the levels of IL-6 (A), IFN-γ (B), KC (C), IP-10 (D),
and MCP-1 (E) in serum were determined by multiplex technology at 24, 48,
and 72h after bacterial inoculation. Each symbol represents the mean ± SD
of the compilation of three independent experiments. ∗p < 0.05.
indication that the greater amount of neutrophils in the lungs
of the later mice is not responsible for the superior resistance
of these animals. To further demonstrate this argument, DT-
treated (DCs-depleted) or PBS-treated (non-depleted) CD11c-
DTR chimera mice were depleted of neutrophils and subse-
quently challenged intranasally with S. pneumoniae. The efficacy
of neutrophil depletion was >95% as shown in Figure 5A. The
pneumococcal burdens were assessed in different tissues at 48 h
of infection. If the superior number of neutrophils present in
the lungs of DCs-depleted mice would be responsible for the
lower bacterial loads detected in the organs of these animals,
an equal amount of bacteria could be expected in the organs
of DCs-depleted and non-depleted mice after neutrophil abla-
tion. As shown in Figure 5, the amount of bacteria in the lungs
(Figure 5B), lymph nodes (Figure 5C), blood (Figure 5D), and
spleen (Figure 5E) was significantly lower in DCs-depleted than
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FIGURE 4 | Cell recruitment in the lungs of DCs-depleted and
non-depleted mice during pneumococcal pneumonia. DCs-depleted
(white bars) and non-depleted (black bars) CD11c-DTR chimera mice were
intranasally infected with 1 × 108 CFU of S. pneumoniae D39, the lungs
taken before (0 h) or at 24 and 48h after bacterial inoculation and dispersed
with collagenase and DNase to obtain a single cell suspension. Cells were
counted (A) and then stained with antibodies against Gr-1 to identify the
neutrophil population (B) by flow cytometry analysis. Each bar represents
the mean ± SD of triplicate samples. One representative experiment out of
three is shown. ∗p < 0.05.
in non-depleted mice in the absence of neutrophils. These results
indicate that the beneficial effect conferred by depletion of DCs
during pneumococcal infection was not the consequence of the
increased number of neutrophils associated with the depletion
procedure.
S. pneumoniae DISSEMINATES FROM THE LUNGS TO THE
MEDIASTINAL LYMPH NODES IN A CELL-INDEPENDENTMANNER
As DCs-depleted mice exhibited a better capacity to restrict
S. pneumoniae extrapulmonary dissemination, we next investi-
gated the potential mechanism by which DCs facilitated S. pneu-
moniae dissemination from the lungs. Evidence has been pro-
vided that DCs can be used by certain pathogens as a “Trojan
horse” or vehicle to disseminate systemically (Pron et al., 2001;
Wu and KewalRamani, 2006; Bierly et al., 2008; Wykes and
Horne-Debets, 2012), we examined whether this could also be
the case for S. pneumoniae. Results in Figures 6A,B revealed a
time-dependent increase in the amount of DCs migrating in
the draining lymphoid tissue after intranasal inoculation with
S. pneumoniae. However, the results of a gentamicin protection
assay indicated that the main fraction of the bacterial population
within the lymph nodes was located extra- rather than intracellu-
larly within the DCs or other cell type (Figure 6C). Additionally,
we determined the ability of bone marrow-derived murine DCs
to phagocyte S. pneumoniae in in vitro assays. DCs were incu-
bated with S. pneumoniae at a MOI of 20:1 for 2 h, unbound
bacteria were removed by washing and DCs were stained for
immune fluorescence examination. To differentiate internalized
from adherent extracellular bacteria we used double immunoflu-
orescence analysis with intracellular bacteria appearing red, while
externally-associated bacteria appear yellow-green and the nuclei
of DCs are stained in blue (Figure 7). As seen in Figure 7C,
the immunofluorescence microscopy examination of infected
DCs further confirmed the low proficiency of DCs to phago-
cyte S. pneumoniae. Increased incubation time or multiplicity of
infection did not improve the frequency of intracellular bacte-
ria but rather compromised the viability of the DCs (data not
shown).
Together, these results suggest that S. pneumoniae dissemi-
nated from the lungs into the regional lymph nodes in a cell-
independent manner and that this mode of dissemination was
much more efficient in the presence of DCs.
S. pneumoniae INDUCES EXPRESSION OF MMP-9 IN DCs
After encountering pathogens in peripheral tissue, immature
DCs recognize microbial components, undergo maturation and
migrate to the regional lymph nodes (Banchereau et al., 2000).
Trafficking of DCs to lymphnodes involves several steps including
the expression of chemokines receptors that regulate DC chemo-
taxis through chemokines gradient as well as transit through
connective tissues and cross basement membranes, which mainly
consist of laminin, type IV collagen, and heparan sulfate pro-
teoglycans (Alvarez et al., 2008). The metalloproteinases MMP-
2 and MMP-9 in particular are especially important in DCs
migration, since they cleave collagen IV, a major component
of basement membranes (Ratzinger et al., 2002; Vermaelen
et al., 2003; Chiyasu et al., 2004). Several pathogens have been
reported to induce the production and activation of MMP-
9 by host cells to open the way through tissue and thereby
to facilitate dissemination within the host (Luplertlop et al.,
2006; Ramu et al., 2008; Nishikaku et al., 2009; Marsac et al.,
2011). Therefore, we next investigated whether S. pneumoniae
might exploit the DC-derived proteolysis to enhance its dis-
semination from the lungs to the regional lymph nodes. To
this end, we analyzed the expression and activity of MMP-9
in DCs after exposure to S. pneumoniae. The results showed
that S. pneumoniae induced mmp-9 gene expression in cul-
tured bone marrow-derived DCs (Figure 8A). S. pneumoniae
also stimulated the activation of MMP-9 released by S. pneu-
moniae-infected DCs to its active isoform as demonstrated by
the gelatinolytic activity of the culture supernatant (Figure 8B).
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FIGURE 5 | Effect of neutrophil depletion in control of S. pneumoniae
by DCs-depleted and non-depleted mice. DT-treated (white bars) and
untreated (black bars) CD11c-DTR chimera mice were depleted of
neutrophils and intranasally infected with 1 × 108 CFU of S. pneumoniae
D39. (A) Histograms showing the percentage of neutrophils in blood
before (left histogram) and after (right histogram) depletion. Bacterial
loads in the lungs (B), mediastinal lymph nodes (C), blood (D), and
spleen (E) were determined at 48h of infection. Each symbol represents
an individual mouse. One representative experiment out of three is
shown. ∗p < 0.05.
MMP-9 was highly up-regulated in the lungs of mice after
intranasal challenge with S. pneumoniae (Figure 8C) and deple-
tion of DCs resulted in significant reduction of MMP-9 lev-
els in the infected lungs (Figure 8D). MMP-2, an additional
metalloproteinase reported to be involved in DCs migration
(Ratzinger et al., 2002), was induced to a lesser extent in the
murine infected lungs (Figure 8D). However, in contrast to
MMP-9, the level of MMP-2 was not affected by the depletion
of DCs (Figure 8D). These results suggest that DCs are largely
involved in the production of MMP-9 during pneumococcal
pneumonia.
Furthermore, functional analysis using an in vivo vascular per-
meability assay revealed that supernatants from DCs infected
with S. pneumoniae had increased basement membrane perme-
ability than those from uninfected DCs (Figures 8E,F). Together,
these results indicate that S. pneumoniae enhances the capacity of
DCs to degrade extracellular matrices and the permeability of the
basement membranes.
DISCUSSION
The results of this study demonstrate that in vivo depletion of
DCs enhanced the resistance of mice to intranasal challenge with
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FIGURE 6 | Trafficking of DCs to the mediastinal lymph nodes after
intranasal infection with S. pneumoniae. DCs-depleted and
non-depleted CD11c-DTR chimera mice were intranasally infected with
1 × 108 CFU of S. pneumoniae, the mediastinal lymph nodes were
removed before (0 h) and at 24, 48, and 72h after bacterial inoculation and
transformed in a single cell suspension. Cells were then counted, stained
with anti-mouse CD11c and anti-mouse CD11b antibodies and analyzed by
flow cytometry. (A) Representative dot plots of DCs in the mediastinal
lymph nodes of S. pneumoniae-infected DCs-depleted (right histograms)
and non-depleted (left histograms) mice. The numbers in each dot
plot represent the percentage of DCs. One representative experiment out of
(Continued)
FIGURE 6 | Continued
three is shown. (B) Total amount of DCs in the mediastinal lymph nodes of
S. pneumoniae-infected DCs-depleted (white symbols) and non-depleted
(black symbols) CD11c-DTR chimera mice. Each symbol represents the
mean ± SD of three independent experiments. (C) Quantification of viable
intracellular (white bars) and extracellular (black bars) S. pneumoniae in the
mediastinal lymph nodes of S. pneumoniae-infectedmice at 24 and 48h
after bacterial inoculation. Each bar represents the mean ± SD of triplicate
samples. One representative experiment out of three is shown. ∗p < 0.05
and ∗∗p < 0.01.
FIGURE 7 | Poor uptake of S. pneumoniae by bone marrow-derived
DCs in in vitro assays. Bone marrow-derived DCs were infected with
S. pneumoniae for 2 h, fixed, and stained for with polyclonal rabbit
anti-S. pneumoniae antibodies, followed by Alexa green-conjugated goat
anti-rabbit antibodies (A). Cells were then permeabilized with 0.025% Triton
X-100 in PBS, and intracellular bacteria were stained by anti-S. pneumoniae
antibodies, followed by Alexa red-conjugated goat anti-rabbit antibodies (B).
In the merged image shown in (C), extracellular bacteria are yellow-green,
intracellular bacteria are red and the DNA in the nucleus of DCs is stained in
blue. The white arrow indicated an intracellular S. pneumoniae. (D) Phase
contrast picture showing the contour of the DCs.
S. pneumoniae. These results are in line with an earlier study
showing that increased numbers of DCs in the lungs of mice
after treatment with FMS-like tyrosine kinase 3 ligand (Flt3L),
which is a hemopoietic growth factor required for DC devel-
opment in peripheral lymphoid tissue (Liu and Nussenzweig,
2010), significantly increased mortality and morbidity of mice
challenged intranasally with pneumococci (Winter et al., 2007).
The improved control of S. pneumoniae infection after DC deple-
tion observed in our study was neither mediated by an increased
recruitment of cells involved in bacterial clearance at the site of
infection nor by increased bactericidal capacity of neutrophils
in the absence of DCs as recently reported in an experimental
mouse model of Yersinia enterocolitica (Autenrieth et al., 2012).
The superior resistance of DCs-depleted mice to S. pneumo-
niae seems to be related to a better capacity to restrict bacterial
dissemination from the local site of infection. Hence, we speculate
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FIGURE 8 | S. pneumoniae triggers production of MMP-9 on in vitro
cultured DCs and in lung tissue during in vivo infection. (A) Bone
marrow-derived DCs were infected with S. pneumoniae (MOI 20:1), RNA
was extracted from DCs at 6 and 24h postinfection and subjected to
real-time PCR for quantification of mmp-9 gene expression. Results are
expressed as fold-change in MMP-9 mRNA of infected DCs over the
amount of MMP-9 mRNA in uninfected DCs. Each bar represents the
mean of three independent experiments. (B) Representative gelatin
zymography demonstrating the up-regulation of the active form of MMP-9
in the supernatant of S. pneumoniae-infected DCs at 24 h postinfection.
(C) Up-regulation of mmp-9 gene expression in the lungs of BALB/c mice
during infection with S. pneumoniae. BALB/c mice were intranasally
infected with 1 × 108 CFU of S. pneumoniae D39, the RNA was isolated
from the lungs at 24 and 48h of infection and subjected to real-time PCR
for detection of MMP-9 mRNA. Each bar represents the mean value of
three independent experiments. (D) Up-regulation of mmp-9 gene
expression in the lungs of DCs-depleted (white bar) or non-depleted (black
bar) CD11c-DTR chimera mice at 24h of infection with 1 × 108 CFU of
S. pneumoniae D39. Each bar represents the mean value of three
independent experiments. (E) Vascular permeability induced by the
supernatant from either S. pneumoniae (1), DCs (2), or
S. pneumoniae-infected DCs (24h postinfection) (3). Supernatant (50μl) was
intradermally applied into the skin of Evans blue-treated mice and vascular
leakage of Evans blue was visualized 1 h thereafter. A representative
experiment out of three is shown. (F) Quantification of Evans blue leakage
in the skin of mice after application of supernatant from S. pneumoniae,
DCs or S. pneumoniae-infected DCs (24h postinfection). Each bar
represents the mean ± SD of three independent experiments. ∗∗p < 0.01.
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that the higher bacterial loads observed in the lungs of non-
depleted animals at 48 h and 72 h of infection in comparison
with DCs-depleted animals are due to bacterial entrapment in the
pulmonary capillaries after been released into the bloodstream
from heavily infected peripheral organs rather than to an inferior
capacity of these animal to eliminate pneumococci.
It has been reported that treatment of CD11c-DTR
mice with DT can also result in the depletion of CD11c+
alveolar macrophages (van Rijt et al., 2005). However,
previous studies using intranasal instillation of liposomal
dichloromethylene-bisphosphonate to achieve specific depletion
of alveolar macrophages demonstrated that depletion of alveolar
macrophages did not affect the bacterial burdens in the lungs
and blood of mice after intranasal infection with S. pneumoniae
(Knapp et al., 2003). Therefore, the benefit conferred by the
depletion of CD11c+ cells on the course of respiratory S. pneu-
moniae infection observed in our study can be attributed to
the depletion of DCs rather than to the depletion of alveolar
macrophages.
To migrate from the lungs to the draining lymph nodes,
S. pneumoniae must traverse tissue barriers such as the epithe-
lium, basal membranes and endothelium. Evidence is accumu-
lating that certain bacterial pathogens can take advantage of the
migratory capacity of DCs and use them as a “Trojan horse” or
vehicle to disseminate systemically (Pron et al., 2001; Wu and
KewalRamani, 2006; Bierly et al., 2008; Wykes and Horne-Debets,
2012). This led us to search for an association between DCs and
S. pneumoniae in the infected lymph nodes. However, we found
that pneumococci were mostly located extracellularly, implying
that S. pneumoniae disseminated from the lungs into the regional
lymph nodes in a cell-free manner. In this regard, proteolytic
cleavage of the extracellular matrix and basement membranes is
a prerequisite for S. pneumoniae to travel from lungs to lymph
nodes. Invasive pathogens such as Pseudomonas aeruginosa and
Clostridium spp. secrete proteases that lead to tissue damage
and thereby enhance bacterial invasiveness (Singh et al., 2012).
On the other hand, a number of invasive bacteria including
S. pneumoniae produce low levels of proteases and therefore they
use a different mechanism for the degradation of extracellu-
lar matrix during tissue penetration. One of these mechanisms
relies on the interaction with the host protease-dependent path-
ways such as fibrinolysis, coagulation, and complement activation
(Bhattacharya et al., 2012). In this regard, S. pneumoniae expresses
surface receptors which capture host plasminogen and thereby
generate and utilize host-derived plasmin activity to degrade
laminin and other glycoproteins in the extracellular matrix and
basement membranes (Eberhard et al., 1999; Bergmann et al.,
2005; Bergmann and Hammerschmidt, 2007). The plasminogen-
plasmin receptors at the surface of S. pneumoniae include
the α-enolase (Bergmann et al., 2001), the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Bergmann et al., 2004)
and the surface-exposed choline-binding protein E (CBPE, also
referred to as Pce) (Attali et al., 2008). Plasmin, however, is not
very efficient in collagen breakdown, whereas the matrix metallo-
proteinases (MMPs) have the ability to degrade collagens, which
are the major components responsible for the barrier function of
the extracellular matrix (Hotary et al., 2000). Notably, we found
that MMP-9 activity was up-regulated in DCs after exposure to
S. pneumoniae.
The process of DCmigration to regional lymph nodes is rather
complex and involves multiple steps each orchestrated by specific
factors. These include chemo-attractants to dictate the direction
of migration (Sallusto et al., 1999; Sozzani et al., 1999), adhe-
sion molecules acting as docking stations (D’Amico et al., 1998),
and proteinases to break physical barriers and to open the way
in the extracellular matrix (D’Amico et al., 1998; Sozzani et al.,
1999). Both metalloproteinase MMP-2 and MMP-9 degrade col-
lagen IV and act as major players in DC migration. In particular,
the role of MMP-9 in DC migration has been demonstrated
in vitro, in skin explant models, and in vivo (Hollender et al.,
2002; Ratzinger et al., 2002; Ichiyasu et al., 2004; Chabot et al.,
2006; Zozulya et al., 2007). We found that MMP-9 was highly
up-regulated in the lungs of mice after intranasal challenge with
S. pneumoniae. Furthermore, depletion of DCs resulted in sig-
nificant reduction in the levels of MMP-9 in the infected lungs,
which supports that DCs are either a direct source of MMP-9
during pneumococcal pneumonia or that they modulate MMP-9
production by other cell types. Thus, it is tempting to specu-
late that the increased production of MMP-9 by DCs during
pneumococcal pneumonia and the resulting breakdown of extra-
cellular matrix and basal membranes on their way to the regional
lymph nodes can open tissue barriers and thereby facilitate the
extrapulmonary dissemination of S. pneumoniae. In agreement
with our results, Yasuda et al. (2010) reported enhanced air-
way resistance to S. pneumoniae associated with suppression of
MMP-9 expression/activation in mice. Furthermore, studies per-
formed in a rat model of pneumococcal meningitis documented
induction of MMPs in brain parenchymal tissue and signifi-
cantly reduced brain injury after MMP chemical inhibition (Leib
et al., 2000, 2001). Elevated blood and bronchoalveolar lavage
levels of different MMPs have also been reported in patients
with pneumonia (Hartog et al., 2003; Yang et al., 2005). More
interestingly, high MMPs levels in these patients were related
to increased clinical severity (Hartog et al., 2003). The MMPs
are produced as inactive precursors and a specific activation
process in the extracellular milieu is required for expression of
their proteolytic activity against extracellular matrix proteins (Ra
and Parks, 2007). In this context, S. pneumoniae has also been
reported to produce or recruit proteases that activate pro-MMPs
(Oggioni et al., 2003).
Murine DCs are an unquestionably valuable tool to investigate
the interactions of DCs with pathogens. Although differences in
the production of cytokines have been reported between human
and murine DCs after in vitro infection with S. pneumoniae
(Littmann et al., 2009), the overall performance of murine DCs
during in vivo infection can be relevant to human DCs since,
like human DCs, murine DCs express receptors for recognition
of bacterial components, they express MHC class II molecules
and costimulatory molecules involved in antigen presentation,
and they mature and migrate in response to danger signals
(Banchereau et al., 2000). Therefore, despite its limitations,
murine DCs remain one of the most important experimental
systems to investigate the role of DCs during infection and exper-
iments in mice have been pivotal to clarify the central role of DCs
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in the immune function. Studies addressing the in vivo function
of DCs in human are scarce. Two genetically defined syndromes
of DC deficiency have recently been described in humans (Bigley
et al., 2011; Collin et al., 2011; Hambleton et al., 2011). Mutation
of GATA-binding factor 2 (GATA2) results in absence of mono-
cytes andDCs (Hambleton et al., 2011) andmutations in the gene
encoding the interferon regulatory factor 8 (IRF8) were found
to compromise DC development in the affected patients (Collin
et al., 2011; Hambleton et al., 2011). The phenotype in both
cases includes susceptibility to infection with Mycobacterium spp.
(Bigley et al., 2011; Collin et al., 2011; Salem and Gros, 2013).
Intriguingly, in any of the cases the patients exhibited increased
susceptibility to S. pneumoniae or other extracellular pathogen.
An impaired production of IL-12 and IFN-γ due to the absence
of monocytes and DCs could partly explain why these patients
exhibit an increased susceptibility to poorly virulent strains of
Mycobacterium spp (Collin et al., 2011). While these cytokines
are essential for the control of mycobacterial infections (Jouanguy
et al., 1999), they play a minor role in host defense against
S. pneumoniae (Lauw et al., 2002). This can provide a plausible
explanation for the lack of susceptibility of DC-deficient patients
to pneumococcal infections.
The pathogenesis of the experimental murine pneumococcal
pneumonia described in this study can be divided into differ-
ent phases: during the very early phase of infection and shortly
after bacterial inoculation, pneumococci will encounter the resi-
dent alveolar macrophages, which will try to phagocyte and kill
the incoming bacteria. S. pneumoniae is capable to survive at
this stage by expressing a thick polysaccharide capsule that inter-
feres with the phagocytic activity of the alveolar macrophages.
The next phase of infection (24 h) is characterized by a massive
influx of neutrophils and bacterial dissemination from the lungs
to the regional lymph nodes. Dissemination of S. pneumoniae at
this stage of infection parallels the migration of DCs from the
lungs to draining lymph nodes. Based on the observations of our
study, it can be speculated that pneumococci take advantage of
the ability of the DCs to open tissue barriers on their way to
the lymph nodes to promote their own dissemination from the
local site of infection. For this reason, the amount of bacteria
reaching the lymph nodes will be much lower in the absence of
DCs. Bacterial colonization of the lymph nodes (24 h of infec-
tion) precedes the appearance of the pathogen in the blood and
the spreading to distant organs where the microorganisms prolif-
erate and establish new focus of infection (48 h of infection). Due
to the lower amount of bacteria reaching the lymphnodes inDCs-
depleted mice, the amount of pneumococci spreading from the
lymph nodes into the bloodstream and systemic organs will also
be lower in mice depleted of DCs. A fraction of the progressively
increasing bacterial burden will be discharged from the infected
organs into the bloodstream and thereby transported to the lungs.
Hence, the higher bacterial loads detected in the lungs of non-
depleted mice at 48 h and 72 h of infection might be the results of
a larger amount of bacteria discharged into the bloodstream from
the more heavily infected systemic organs.
Taken together, our results suggest that modulation of DCs
during pneumococcal pneumonia might provide an inter-
esting means to prevent or delay extrapulmonary bacterial
dissemination.
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